查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1591986

免疫蛋白质诊断测试市场：按技术、免疫蛋白质类型、应用和最终用户划分 - 2025-2030 年全球预测

Immunoprotein Diagnostic Testing Market by Technology, Immunoprotein Type, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

免疫蛋白诊断测试市场2023年估值为88.1亿美元，预计到2024年将达到94.1亿美元，复合年增长率为6.92%，到2030年将达到140.7亿美元。

免疫蛋白诊断测试市场包括分析和利用与免疫反应相关的蛋白质来检测、监测和管理疾病。这些测试对于诊断各种疾病（例如自体免疫疾病、感染疾病、癌症和过敏）至关重要。这些测试在个人化医疗中发挥重要作用，可实现精确的治疗策略并改善患者的治疗结果。其应用范围广泛，包括医院、诊断实验室、学术机构和研究机构。该市场是由慢性病患病率不断上升、技术进步以及对疾病早期检测和预防日益增长的兴趣所推动的。推动成长的因素包括人工智慧和机器学习在诊断中的集成，以及测试准确性和效率的提高。远端医疗和数位医疗平台的扩展为远端患者监护提供了新途径，进一步推动了市场需求。然而，先进诊断工具的高成本和监管挑战构成了主要障碍。此外，免疫蛋白质相互作用的复杂性需要不断创新，并需要在研发方面进行大量投资。新兴市场趋势凸显了开发经济高效、快速、可携式诊断解决方案的重要性。生物技术公司和研究机构之间的合作有可能在检测开发和生物标记发现方面取得突破，从而提高测试的特异性和敏感性。透过专注于自动化测试流程和整合巨量资料分析，公司可以透过缩短交付时间并从测试结果中获得更深入的见解来提高竞争力。最后，诊断测试开发和部署中的永续性和道德考量变得越来越重要，为优先考虑绿色和社会责任运营的公司提供了机会。拥抱这些创新，同时克服现有的限制，将有助于抓住潜在的成长机会，并维持免疫蛋白诊断测试产业的长期市场影响。

主要市场统计
基准年[2023] 88.1亿美元
预测年份 [2024] 94.1亿美元
预测年份 [2030] 140.7亿美元
复合年增长率（%） 6.92%

市场动态：快速发展的免疫蛋白诊断测试市场的关键市场洞察

供需的动态交互作用正在改变免疫蛋白诊断测试市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 感染疾病和慢性病的发生率和盛行率增加
    • 新兴国家对早期诊断服务的需求不断增长
    • 诊断测试的增加和对化学冷光检测的需求不断增长
  • 市场限制因素
    • 免疫蛋白诊断测试成本高
  • 市场机会
    • 免疫诊断设备的技术进步，引进新的自动化系统
    • 持续开发疾病特异性分析与测试
  • 市场挑战
    • 核准免疫蛋白诊断测试的复杂法律规范

波特五力：开拓免疫蛋白诊断测试市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解免疫蛋白诊断测试市场的外部影响

外部宏观环境因素在塑造免疫蛋白诊断测试市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解免疫蛋白质诊断测试市场的竞争格局

对免疫蛋白诊断测试市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵免疫蛋白诊断测试市场供应商绩效评估

FPNV 定位矩阵是评估免疫蛋白诊断测试市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划免疫蛋白诊断测试市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对免疫蛋白诊断测试市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 感染疾病和慢性病的发生率和盛行率增加
      • 新兴国家对早期诊断服务的需求不断增加
      • 诊断测试的增加和对化学冷光检测的需求增加
    • 抑制因素
      • 免疫蛋白诊断测试高成本
    • 机会
      • 介绍免疫诊断设备和新型自动化系统的技术进步
      • 持续开发疾病特异性分析与测试
    • 任务
      • 核准免疫蛋白诊断测试的复杂法规结构
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章免疫蛋白诊断测试市场：依技术分类

  • 酵素免疫分析法
  • 萤光测定
  • 免疫检测

第七章以免疫蛋白质类型分類的免疫蛋白质诊断测试市场

  • C反应蛋白
  • 补体系统蛋白
  • 免疫球蛋白

第八章免疫蛋白诊断测试市场：依应用分类

  • 过敏测试
  • 自体免疫疾病检测
  • 内分泌检查
  • 传染病检查
  • 肿瘤检查
  • 毒性试验

第九章免疫蛋白诊断测试市场：依最终用户分类

  • 诊断实验室
  • 医院/诊所
  • 调查机构

第十章美洲免疫蛋白诊断测试市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太免疫蛋白诊断检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲免疫蛋白诊断测试市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Abcam PLC
  • Beckman Coulter Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Bio-Techne Corporation
  • BioMerieux SA
  • Calbiotech, Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • DiaSys Diagnostic Systems GmbH
  • Diazyme Laboratories Inc.
  • Enzo Biochem Inc.
  • F. Hoffmann-La Roche AG
  • Grifols, SA
  • Luminex Corporation
  • Miraca Holdings Inc.
  • Ortho Clinical Diagnostics
  • QIAGEN NV
  • Randox Laboratories Ltd.
  • SERVA Electrophoresis GmbH
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Werfen
Product Code: MRR-FF012EDC38AF

The Immunoprotein Diagnostic Testing Market was valued at USD 8.81 billion in 2023, expected to reach USD 9.41 billion in 2024, and is projected to grow at a CAGR of 6.92%, to USD 14.07 billion by 2030.

The immunoprotein diagnostic testing market encompasses the analysis and utilization of proteins related to the immune response for disease detection, monitoring, and management. These tests are vital in diagnosing various conditions such as autoimmune disorders, infectious diseases, cancers, and allergies. They play a crucial role in personalized medicine, enabling precise treatment strategies and improving patient outcomes. The application spans across hospitals, diagnostic laboratories, academic institutes, and research organizations. The market is driven by an increasing prevalence of chronic diseases, advancements in technology, and a heightened focus on early disease detection and prevention. Factors propelling growth include the integration of AI and machine learning in diagnostics, elevating the accuracy and efficiency of tests. The expansion of telemedicine and digital healthcare platforms offers new avenues for remote patient monitoring, further fueling market demand. However, the high cost of sophisticated diagnostic tools and regulatory challenges pose significant hurdles. Furthermore, the complexity of immunoprotein interactions requires continuous innovations, demanding substantial investment in research and development. Emerging trends highlight the importance of developing cost-effective, rapid, and portable diagnostic solutions to increase access in underserved regions, potentially broadening market reach. Collaborations between biotech firms and research institutions could yield breakthroughs in assay development and biomarker discovery, enhancing test specificity and sensitivity. For businesses, focusing on automation in testing processes and the integration of big data analytics could provide a competitive edge by reducing turnaround times and extracting deeper insights from test results. Lastly, sustainability and ethical considerations in the development and deployment of diagnostic tests are gaining importance, offering opportunities for companies that prioritize eco-friendly and socially responsible operations. Embracing these innovations while navigating existing limitations can help capture potential growth opportunities and sustain long-term market presence in the immunoprotein diagnostic testing industry.

KEY MARKET STATISTICS
Base Year [2023] USD 8.81 billion
Estimated Year [2024] USD 9.41 billion
Forecast Year [2030] USD 14.07 billion
CAGR (%) 6.92%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Immunoprotein Diagnostic Testing Market

The Immunoprotein Diagnostic Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in incidence and prevalence of infectious and chronic diseases
    • Growth in demand for early diagnostic services in emerging economies
    • Rise in diagnostic tests and growing demand for chemiluminescence assay
  • Market Restraints
    • High cost of immunoprotein diagnostic tests
  • Market Opportunities
    • Technological advancements in immunodiagnostic instruments and the introduction of novel automated systems
    • Ongoing development in the condition-specific assays and tests
  • Market Challenges
    • Complex regulatory framework for the approval of immunoprotein diagnostic tests

Porter's Five Forces: A Strategic Tool for Navigating the Immunoprotein Diagnostic Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Immunoprotein Diagnostic Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Immunoprotein Diagnostic Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Immunoprotein Diagnostic Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Immunoprotein Diagnostic Testing Market

A detailed market share analysis in the Immunoprotein Diagnostic Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Immunoprotein Diagnostic Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Immunoprotein Diagnostic Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Immunoprotein Diagnostic Testing Market

A strategic analysis of the Immunoprotein Diagnostic Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Immunoprotein Diagnostic Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, Beckman Coulter Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corporation, BioMerieux S.A., Calbiotech, Inc., Danaher Corporation, DiaSorin S.p.A., DiaSys Diagnostic Systems GmbH, Diazyme Laboratories Inc., Enzo Biochem Inc., F. Hoffmann-La Roche AG, Grifols, S.A., Luminex Corporation, Miraca Holdings Inc., Ortho Clinical Diagnostics, QIAGEN N.V., Randox Laboratories Ltd., SERVA Electrophoresis GmbH, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific Inc., and Werfen.

Market Segmentation & Coverage

This research report categorizes the Immunoprotein Diagnostic Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Enzyme-Linked Immunoassay, Immunofluorescence Assay, and Radioimmunoassay.
  • Based on Immunoprotein Type, market is studied across C-reactive Protein, Complement System Protein, and Immunoglobulin.
  • Based on Application, market is studied across Allergy Testing, Autoimmune Disease Testing, Endocrine Testing, Infectious Disease Testing, Oncology Testing, and Toxicology Testing.
  • Based on End-User, market is studied across Diagnostic Laboratories, Hospitals & Clinics, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in incidence and prevalence of infectious and chronic diseases
      • 5.1.1.2. Growth in demand for early diagnostic services in emerging economies
      • 5.1.1.3. Rise in diagnostic tests and growing demand for chemiluminescence assay
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of immunoprotein diagnostic tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in immunodiagnostic instruments and the introduction of novel automated systems
      • 5.1.3.2. Ongoing development in the condition-specific assays and tests
    • 5.1.4. Challenges
      • 5.1.4.1. Complex regulatory framework for the approval of immunoprotein diagnostic tests
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Immunoprotein Diagnostic Testing Market, by Technology

  • 6.1. Introduction
  • 6.2. Enzyme-Linked Immunoassay
  • 6.3. Immunofluorescence Assay
  • 6.4. Radioimmunoassay

7. Immunoprotein Diagnostic Testing Market, by Immunoprotein Type

  • 7.1. Introduction
  • 7.2. C-reactive Protein
  • 7.3. Complement System Protein
  • 7.4. Immunoglobulin

8. Immunoprotein Diagnostic Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Allergy Testing
  • 8.3. Autoimmune Disease Testing
  • 8.4. Endocrine Testing
  • 8.5. Infectious Disease Testing
  • 8.6. Oncology Testing
  • 8.7. Toxicology Testing

9. Immunoprotein Diagnostic Testing Market, by End-User

  • 9.1. Introduction
  • 9.2. Diagnostic Laboratories
  • 9.3. Hospitals & Clinics
  • 9.4. Research Institutes

10. Americas Immunoprotein Diagnostic Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Immunoprotein Diagnostic Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Immunoprotein Diagnostic Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Abcam PLC
  • 3. Beckman Coulter Inc.
  • 4. Becton, Dickinson and Company
  • 5. Bio-Rad Laboratories Inc.
  • 6. Bio-Techne Corporation
  • 7. BioMerieux S.A.
  • 8. Calbiotech, Inc.
  • 9. Danaher Corporation
  • 10. DiaSorin S.p.A.
  • 11. DiaSys Diagnostic Systems GmbH
  • 12. Diazyme Laboratories Inc.
  • 13. Enzo Biochem Inc.
  • 14. F. Hoffmann-La Roche AG
  • 15. Grifols, S.A.
  • 16. Luminex Corporation
  • 17. Miraca Holdings Inc.
  • 18. Ortho Clinical Diagnostics
  • 19. QIAGEN N.V.
  • 20. Randox Laboratories Ltd.
  • 21. SERVA Electrophoresis GmbH
  • 22. Siemens Healthineers
  • 23. Sysmex Corporation
  • 24. Thermo Fisher Scientific Inc.
  • 25. Werfen

LIST OF FIGURES

  • FIGURE 1. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOFLUORESCENCE ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY C-REACTIVE PROTEIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COMPLEMENT SYSTEM PROTEIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ALLERGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ENDOCRINE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ONCOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 195. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, FPNV POSITIONING MATRIX, 2023